Search results
Found 429 matches for
Potential new route to treatment for Cerebellar Ataxia?
18 September 2017
Researchers from the teams of Andrea Németh (NDCN) and Esther Becker (DPAG) have published an important paper reporting dominant mutations that cause a new type of cerebellar ataxia, Spinocerebellar Ataxia type 44.
James Parkinson 200th anniversary events
14 September 2017
This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.
New consortium to investigate Alzheimer’s and Parkinson’s diseases
10 April 2017
New research project could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases.
Cannabinoid biomedicine research programme launched
17 March 2017
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.
New Oxford Neurodevelopment Consortium
13 January 2017
Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).
New drug trial for Parkinson's
12 December 2016
Our researchers have been granted 600K euros from EU’s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson's disease
Brain activity predicts the force of your actions
24 November 2016
A clear link between the activity in nerve clusters in the brain and the amount of force generated in a physical action has been demonstrated by our researchers, opening the way for the development of better devices to assist paralysed patients.
Study paves the way for new autoimmune disease treatments with fewer side effects
3 November 2016
New research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.
Medical Research Council awards £4.3m to boost UK research base in dementia
25 October 2016
Six universities including Oxford have been awarded a total of £4.3m by the Medical Research Council (MRC) to grow and develop the UK’s research base in dementia science.
New test for Parkinson’s disease moves a step closer
1 September 2016
Scientists from the Oxford Parkinson’s Disease Centre (OPDC) and the Edinburgh Prion Unit have developed a new diagnostic test for Parkinson’s disease. The test measures the 'stickiness' of a particular protein in the cerebrospinal fluid.
Spinout develops smart glasses
9 August 2016
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
Researcher wins prize for engaging the public
1 July 2016
The 12 winners of the inaugural University of Oxford's Vice-Chancellor’s Awards for Public Engagement with Research were announced on Friday 1 July by the Vice-Chancellor, Professor Louise Richardson, in a ceremony at Merton College.
Scientists pinpoint molecular signal that drives and enables spinal cord repair
23 March 2016
Dave Bennett and colleagues from King's College London have identified a molecular signal which drives and enables the spinal cord’s natural capacity for repair after injury. The findings could one day lead to new treatments which enhance this spontaneous repair mechanism..
Teaching old drugs new tricks
24 November 2015
Researchers looking at multiple sclerosis investigate using drugs normally prescribed for other diseases.